Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Plans form around your needs, not trends or guesses
In the 12mg arm, some participants lost over 30% of their body weight while others lost under 15%
Semaglutides cardiovascular outcomes trials (such as the SUSTAIN and SELECT programmes) have generally shown neutral or beneficial effects on major cardiovascular outcomes and no significant increase in clotting events compared to placebo
Insurance coverage and patient assistance programs can substantially lower out-of-pocket costs
US$ 24.65
US$ 27.95
US$ 24.00
US$ 23.93
US$ 26.03
US$ 26.22
US$ 24.92
US$ 20.91
